Bombay Company (fka BBAO) : do you guys still like BBAO? doesn't the...

lifegear · 2008-03-03T18:51:22.6830000Z

do you guys still like BBAO? doesn't the current shareholders retain 25% of the new company?

Play Episode

6min

Proactive - Interviews for investors

Novo Resources targets gold at Tibooburra

Novo Resources Corp executive co-chair Mike Spreadborough and exploration manager Kas De Luca talked with Proactive about the company’s current exploration, strategy and key drilling campaigns underway in 2025. Spreadborough detailed the company's focus on standalone projects with the potential to exceed one million ounces, with current efforts centred on drilling programs at the Balla Balla project, Tibooburra Gold Project, and upcoming activity at the John Bull Project. “We’re not chasing brownfields mill feed for an existing processing plant. We’re looking for something new and exciting,” he said. De Luca shared insights into the Clone prospect at Tibooburra, highlighting its strong geological context and mineralisation indicators. “The clone thrust has been really identified and pinpointed now as a foot wall shear zone… that seems to us both in the drilling and in service to carry most of the mineralisation,” she noted. De Luca said results from surface sampling returned grades up to 89 grams per tonne, and the company has only tested a small fraction of a 60km mineralised trend. Novo expects results from three programs between now and July and continues to assess additional farm-in opportunities as part of its strategy. For more videos from Proactive, give this video a like, subscribe to our channel, and turn on notifications so you never miss an update. #GoldExploration #NovoResources #TibooburraGold #GreenfieldsExploration #JuniorMining #RCDrilling #GoldStocks #AustralianMining #MiningUpdates #ProactiveInvestors

Proactive - Interviews for investors

St George Mining unveils major JORC resource

St George Mining Ltd executive chairman John Prineas talked with Proactive about the company's newly announced maiden JORC resource, which he says could be among the world’s most significant niobium and rare earth deposits. Prineas said the deposit features over 500 intercepts of high-grade mineralisation and boasts a rare combination of high grades and shallow mineralisation starting at surface, supporting an open pit development. “We think, possibly the second highest niobium deposit in terms of grade and, probably one of the highest rare earth deposits,” he told Proactive. He confirmed the company has already seen interest from industry players, with some expressing interest in potential partnerships and even mergers. The resource was released following St George’s acquisition of the project in late February, and the company has committed to a drill program starting in the coming weeks. According to Prineas, this program could potentially double the existing resource. In Brazil, St George has assembled an experienced in-country team and engaged a global EPC contractor to progress mine development. The company has also begun metallurgical and downstream processing studies and believes the project will deliver a commercial-grade product, supported by decades of similar production by neighbours CBMM. 👉 For more interviews like this, visit Proactive's YouTube channel. Don’t forget to like this video, subscribe, and enable notifications so you never miss an update. #StGeorgeMining #Niobium #RareEarths #JORCResource #MiningExploration #ASX #CriticalMinerals #BrazilMining #ResourceUpdate #MineralDiscovery #JohnPrineas #ProactiveInvestors

Proactive - Interviews for investors

Directa Plus CEO on Q1 revenue jump on new contracts in Romania and textile market recovery

Directa Plus CEO Giulio Cesareo talked with Proactive's Stephen Gunnion about the company’s strong start to 2025 and the strategic impact of its environmental operations. Cesareo shared that the company saw a 40% rise in first-quarter revenue to approximately €2 million, driven by new contracts in Romania and a recovering textile market in Italy. “We have a significant contract with Midia International,” Cesareo explained, adding that work on oil recovery from drilling platforms resumed after a slowdown in 2024 due to the war in the Black Sea. The full acquisition of Setcar, a Romanian environmental service company, plays a central role in the company’s strategy. Cesareo highlighted that Setcar not only holds a full suite of environmental certifications but also occupies a “geopolitical significant position” as a potential gateway to Ukraine’s reconstruction. Environmental applications remain a key focus for Directa Plus, especially the use of its graphene materials to decontaminate water and soil. In collaboration with OMV Petrom, the company successfully decontaminated 44,000 cubic meters of water, recovering 10,000 barrels of crude oil. Research and development are also advancing. Directa Plus is working with Nant G Power on battery materials and refocusing on opportunities in sectors like tyres and PFAS filtration. Cesareo stated, “There are significant opportunities, despite the actual crisis, that can be captured by our innovative material.” With €4 million in cash and a burn rate that extends funding through to August 2026, Cesareo believes the company is well-positioned for the year ahead. For more exclusive interviews and updates, visit Proactive's YouTube channel. Don’t forget to like this video, subscribe, and enable notifications to stay up to date. #DirectaPlus #GrapheneTechnology #EnvironmentalSolutions #Setcar #OilRecovery #PFAS #CleanTech #NantGPower #UkraineReconstruction #TextileInnovation #BatteryMaterials #Q12025 #InvestingInGraphene #Proa

Proactive - Interviews for investors

NanoViricides highlights broad-spectrum antiviral strategy and progress with lead drug candidate

NanoViricides Chief Financial Officer Meeta Vyas joined Steve Darling from Proactive to share updates on the company’s development of broad-spectrum antiviral therapeutics and its unique positioning amid global market uncertainty. Vyas emphasized that NanoViricides, headquartered in Shelton, Connecticut, conducts all of its research and development in-house, which insulates the company from international tariff fluctuations and supply chain disruptions. At the center of the company’s pipeline is NV-387, a broad-spectrum antiviral drug that differs from vaccines in both function and strategy. Rather than targeting specific viral strains, NV-387 works by mimicking the receptor sites used by over 90% of pathogenic viruses—including influenza, RSV, COVID-19, and smallpox. Vyas explained that this approach helps circumvent the problem of viral mutation, which often renders traditional vaccines less effective. “Regardless of how they mutate, they land on the same receptor site. So we copy the receptor site, which is invariant to mutation,” she said, underscoring the robustness of the NanoViricides platform. She also highlighted supportive regulatory developments in the U.S., noting that the new HHS administration has endorsed a more integrated approach to pandemic preparedness, which includes therapeutics like NV-387 as a key component. In light of recent USDA funding initiatives aimed at combating H5N1 avian flu, Vyas said the company is keen to explore applications of NV-387 in that space as well. Currently, NanoViricides is conducting a Phase 2 clinical trial targeting smallpox, following successful Phase 1 results with no reported adverse effects. #proactiveinvestors #nanoviricidesinc #nyseamerican #nnvc NV387 #BroadSpectrumAntiviral #BiotechStocks #AntiviralTherapeutics #SmallpoxTreatment #BirdFlu #RSV #COVID19Treatment #ProactiveInvestors #PharmaInnovation #MeetaVyas #HHS #PandemicPreparedness

Followers	374
Posts	48150
Boards Moderated	2
Alias Born	10/27/2005

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Join the InvestorsHub Community

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Join the InvestorsHub Community

Go Ad-Free